Proparco supports the growth of the Vitalis Group, a leading pharmaceutical company in Latin America
Proparco, alongside Acon Investments, DEG and FMO, acquired the Vitalis Group (Vitalis), a leading manufacturer and distributor of generic injectable pharmaceuticals with production facilities in Colombia and Mexico. This acquisition will support Vitalis’ growth and facilitate access to affordable medicines in Latin America.
Published on